Literature DB >> 9626847

Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996.

B M Weiss1, L Zemp, B Seifert, O M Hess.   

Abstract

OBJECTIVES: Published reports were reviewed to evaluate the characteristics of peripartal management and the late pregnancy outcome in women with pulmonary vascular disease (PVD).
BACKGROUND: Pulmonary hypertension poses one of the highest risks for maternal mortality, but actual data on the maternal and neonatal prognosis in this group are lacking.
METHODS: Reports published from 1978 through 1996 of Eisenmenger's syndrome (n = 73), primary pulmonary hypertension (PPH) (n = 27) and secondary vascular pulmonary hypertension (SVPH) (n = 25) complicating late pregnancy were included and analyzed using logistic regression analysis.
RESULTS: Maternal mortality was 36% in Eisenmenger's syndrome, 30% in PPH and 56% (p < 0.08 vs. other two groups) in SVPH. Except for three prepartal deaths due to Eisenmenger's syndrome, all fatalities occurred within 35 days after delivery. Neonatal survival ranging from 87% to 89% was similar in the three groups. Previous pregnancies, timing of the diagnosis and hospital admission, operative delivery and diastolic pulmonary artery pressure were significant univariate (p < 0.05) maternal risk factors. Late diagnosis (p = 0.002, odds ratio 5.4) and late hospital admission (p = 0.01, odds ratio 1.1 per week of pregnancy) were independent predictive risk factors of maternal mortality.
CONCLUSIONS: In the last two decades maternal mortality was comparable in patients with Eisenmenger's syndrome and PPH; however, it was relevantly higher in SVPH. Maternal prognosis depends on the early diagnosis of PVD, early hospital admission, individually tailored treatment during pregnancy and medical therapy and care focused on the postpartal period.

Entities:  

Mesh:

Year:  1998        PMID: 9626847     DOI: 10.1016/s0735-1097(98)00162-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  95 in total

1.  Primary pulmonary hypertension in pregnancy.

Authors:  P S Wong; S Constantinides; V Kanellopoulos; C R Kennedy; D Watson; M F Shiu
Journal:  J R Soc Med       Date:  2001-10       Impact factor: 5.344

Review 2.  Heart disease and pregnancy.

Authors:  S C Siu; J M Colman
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

Review 3.  Pregnancy in heart disease.

Authors:  S A Thorne
Journal:  Heart       Date:  2004-04       Impact factor: 5.994

4.  Cardiοvascular diseases in pregnancy.

Authors:  Dimitrios Godosis; Spyridon Komaitis; Konstantinos Tziomalos; Maria Baltatzi; Georgios Ntaios; Christos G Savopoulos; Apostolos I Hatzitolios
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

5.  Cardiac disease in pregnancy: value of echocardiography.

Authors:  Sarah Tsiaras; Athena Poppas
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

6.  Giant, high pressure pulmonary artery aneurysm in a grand multiparous woman.

Authors:  A Akcay; S Koroglu; M Koleoglu; A Suner; G Acar; A Sokmen
Journal:  Neth Heart J       Date:  2010-10       Impact factor: 2.380

Review 7.  Risks of contraception and pregnancy in heart disease.

Authors:  Sara Thorne; Anne MacGregor; Catherine Nelson-Piercy
Journal:  Heart       Date:  2006-10       Impact factor: 5.994

Review 8.  Pulmonary hypertension in women.

Authors:  Meredith E Pugh; Anna R Hemnes
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-11

Review 9.  Pulmonary hypertension-"state of the art" management in 2012.

Authors:  Anita Saxena
Journal:  Indian Heart J       Date:  2012-03-26

10.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: shunt lesions.

Authors:  Candice K Silversides; Annie Dore; Nancy Poirier; Dylan Taylor; Louise Harris; Matthias Greutmann; Lee Benson; Helmut Baumgartner; David Celermajer; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.